S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
NYSE:EW

Edwards Lifesciences Stock Competitors

$108.48
-1.34 (-1.22%)
(As of 12/3/2021 12:00 AM ET)
Add
Compare
Today's Range
$107.15
$111.44
50-Day Range
$106.37
$120.04
52-Week Range
$78.44
$123.27
Volume
3.09 million shs
Average Volume
2.30 million shs
Market Capitalization
$67.73 billion
P/E Ratio
46.16
Dividend Yield
N/A
Beta
1.06

Edwards Lifesciences (NYSE:EW) Vs. ABT, MDT, ISRG, SYK, BDX, BSX, DXCM, IDXX, BAX, and RMD

Should you be buying Edwards Lifesciences stock or one of its competitors? The main competitors of Edwards Lifesciences include Abbott Laboratories (ABT), Medtronic (MDT), Intuitive Surgical (ISRG), Stryker (SYK), Becton, Dickinson and (BDX), Boston Scientific (BSX), DexCom (DXCM), IDEXX Laboratories (IDXX), Baxter International (BAX), and ResMed (RMD). These companies are all part of the "health care equipment" industry.

Edwards Lifesciences vs.

Medtronic (NYSE:MDT) and Edwards Lifesciences (NYSE:EW) are both large-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, valuation, media sentiment, analyst recommendations, community ranking, institutional ownership, profitability and earnings.

Medtronic has higher revenue and earnings than Edwards Lifesciences. Medtronic is trading at a lower price-to-earnings ratio than Edwards Lifesciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medtronic$30.12 billion4.77$3.61 billion$3.4730.80
Edwards Lifesciences$4.39 billion15.44$823.40 million$2.3546.16

79.6% of Medtronic shares are held by institutional investors. Comparatively, 80.6% of Edwards Lifesciences shares are held by institutional investors. 0.5% of Medtronic shares are held by insiders. Comparatively, 1.4% of Edwards Lifesciences shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Medtronic currently has a consensus target price of $144.21, suggesting a potential upside of 34.94%. Edwards Lifesciences has a consensus target price of $120.00, suggesting a potential upside of 10.62%. Given Medtronic's stronger consensus rating and higher possible upside, research analysts plainly believe Medtronic is more favorable than Edwards Lifesciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Medtronic
0 Sell rating(s)
5 Hold rating(s)
16 Buy rating(s)
0 Strong Buy rating(s)
2.76
Edwards Lifesciences
0 Sell rating(s)
7 Hold rating(s)
12 Buy rating(s)
0 Strong Buy rating(s)
2.63

Medtronic has a beta of 0.8, indicating that its stock price is 20% less volatile than the S&P 500. Comparatively, Edwards Lifesciences has a beta of 1.06, indicating that its stock price is 6% more volatile than the S&P 500.

In the previous week, Medtronic had 19 more articles in the media than Edwards Lifesciences. MarketBeat recorded 26 mentions for Medtronic and 7 mentions for Edwards Lifesciences. Edwards Lifesciences' average media sentiment score of 0.24 beat Medtronic's score of -0.02 indicating that Edwards Lifesciences is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Medtronic
4 Very Positive mention(s)
2 Positive mention(s)
13 Neutral mention(s)
1 Negative mention(s)
2 Very Negative mention(s)
Neutral
Edwards Lifesciences
2 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Medtronic received 317 more outperform votes than Edwards Lifesciences when rated by MarketBeat users. Likewise, 79.20% of users gave Medtronic an outperform vote while only 74.35% of users gave Edwards Lifesciences an outperform vote.

CompanyUnderperformOutperform
MedtronicOutperform Votes
1546
79.20%
Underperform Votes
406
20.80%
Edwards LifesciencesOutperform Votes
1229
74.35%
Underperform Votes
424
25.65%

Edwards Lifesciences has a net margin of 29.00% compared to Medtronic's net margin of 14.80%. Edwards Lifesciences' return on equity of 28.13% beat Medtronic's return on equity.

Company Net Margins Return on Equity Return on Assets
Medtronic 14.80% 14.52% 8.01%
Edwards Lifesciences 29.00% 28.13% 18.50%

Summary

Medtronic and Edwards Lifesciences tied by winning 9 of the 18 factors compared between the two stocks.


New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment >-1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

Edwards Lifesciences (NYSE:EW) vs. Its Competitors

TypeEdwards LifesciencesSurgical appliances & supplies IndustryMedical SectorNYSE Exchange
Market Cap$68.56B$10.84B$4.91B$15.26B
Dividend YieldN/A1.19%2.08%3.19%
P/E Ratio46.1620.6816.9219.32
Price / Sales15.4446.342,453.8131.19
Price / Cash53.4330.1364.6988.50
Price / Book12.2210.856.337.59
Net Income$823.40M$148.46M$95.98M$382.44M
7 Day Performance-0.95%-8.73%-6.31%-3.08%
1 Month Performance-7.57%-17.55%-15.25%-6.92%
1 Year Performance26.49%-8.91%7.52%21.42%

Edwards Lifesciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ABT
Abbott Laboratories
2.7764 of 5 stars
$130.27
-1.5%
$136.57
-4.8%
+21.1%$227.01B$34.61B32.33109,000
MDT
Medtronic
3.4595 of 5 stars
$106.87
-0.4%
$144.21
-34.9%
-5.0%$144.17B$30.12B30.8090,000
ISRG
Intuitive Surgical
1.6914 of 5 stars
$321.63
-1.8%
$335.40
-4.3%
+27.2%$116.93B$4.36B69.428,081Short Interest ↓
SYK
Stryker
3.1489 of 5 stars
$246.87
-0.2%
$288.80
-17.0%
+5.1%$93.09B$14.35B49.672,020
BDX
Becton, Dickinson and
2.8809 of 5 stars
$244.12
-0.9%
$273.63
-12.1%
+2.4%$68.72B$20.25B35.6470,000
BSX
Boston Scientific
2.5421 of 5 stars
$39.46
-0.4%
$49.48
-25.4%
+16.7%$56.43B$9.91B54.0538,000Short Interest ↓
News Coverage
DXCM
DexCom
2.5562 of 5 stars
$519.49
-7.8%
$580.20
-11.7%
+50.7%$54.30B$1.93B99.336,400Insider Selling
High Trading Volume
IDXX
IDEXX Laboratories
2.2031 of 5 stars
$586.54
-2.1%
$686.40
-17.0%
+27.5%$50.79B$2.71B67.199,300Insider Selling
BAX
Baxter International
2.6498 of 5 stars
$78.05
-2.3%
$90.82
-16.4%
+2.3%$38.17B$11.67B32.6650,000Short Interest ↓
RMD
ResMed
1.9865 of 5 stars
$254.78
-0.4%
$244.43
-4.1%
+22.8%$37.13B$3.20B74.727,970Insider Selling
STE
STERIS
2.6998 of 5 stars
$219.57
-0.5%
$248.80
-13.3%
+13.9%$21.96B$3.11B78.4213,000
HOLX
Hologic
2.3148 of 5 stars
$73.94
-0.2%
$87.90
-18.9%
+2.0%$18.55B$5.63B10.276,705
PODD
Insulet
2.1331 of 5 stars
$263.17
-9.1%
$311.20
-18.3%
+3.0%$18.15B$904.40M-584.821,900High Trading Volume
MASI
Masimo
2.1231 of 5 stars
$276.97
-1.6%
$308.33
-11.3%
+5.9%$15.29B$1.14B69.075,300
TFX
Teleflex
2.7665 of 5 stars
$305.22
-2.3%
$445.20
-45.9%
-19.3%$14.30B$2.54B33.3614,000Analyst Downgrade
Insider Buying
High Trading Volume
ABMD
Abiomed
2.2064 of 5 stars
$300.63
-3.9%
$363.75
-21.0%
+12.7%$14.22B$847.52M92.791,725Short Interest ↑
HRC
Hill-Rom
2.5131 of 5 stars
$155.68
-0.1%
$144.00
-7.5%
+63.8%$10.29B$3.02B41.8510,000Short Interest ↑
GMED
Globus Medical
2.5582 of 5 stars
$63.05
-0.9%
$87.73
-39.1%
+5.8%$6.42B$789.04M34.832,200Short Interest ↓
IART
Integra LifeSciences
2.0193 of 5 stars
$62.69
-1.5%
$76.75
-22.4%
+14.1%$5.39B$1.37B24.683,700News Coverage
ATRC
AtriCure
2.2989 of 5 stars
$65.20
-4.2%
$90.50
-38.8%
+48.1%$2.99B$206.53M68.63750Short Interest ↓
ITGR
Integer
2.4281 of 5 stars
$80.23
-1.9%
$108.00
-34.6%
+5.8%$2.70B$1.07B30.057,500News Coverage
NUVA
NuVasive
2.1438 of 5 stars
$47.80
-2.8%
$66.92
-40.0%
+1.1%$2.47B$1.05B-93.732,700Short Interest ↑
ATEC
Alphatec
2.4172 of 5 stars
$10.75
-2.8%
$20.64
-92.0%
-1.7%$1.07B$144.86M-7.52296Analyst Report
Insider Buying
Short Interest ↓
ANGO
AngioDynamics
2.4015 of 5 stars
$25.64
-3.5%
$34.50
-34.6%
+81.3%$1.03B$291.01M-28.81800Analyst Downgrade
Short Interest ↓
CSII
Cardiovascular Systems
2.0219 of 5 stars
$18.99
-3.9%
$43.40
-128.5%
-44.8%$800.07M$258.97M-37.24779
CRY
CryoLife
2.6248 of 5 stars
$17.84
-4.3%
$35.50
-99.0%
-14.0%$701.65M$253.23M594.861,200Insider Buying
SRDX
Surmodics
2.2314 of 5 stars
$43.43
-2.1%
$70.00
-61.2%
+12.0%$603.89M$105.14M144.77370Insider Selling
Short Interest ↓
OFIX
Orthofix Medical
1.7431 of 5 stars
$30.24
-3.7%
N/A-16.6%$597.09M$406.56M-39.271,036Analyst Upgrade
Short Interest ↓
ARAY
Accuray
1.9214 of 5 stars
$4.86
-2.5%
N/A+20.0%$452.78M$396.29M-60.75932
IVC
Invacare
2.1365 of 5 stars
$2.41
-5.0%
$8.50
-252.7%
-71.7%$88.61M$850.69M-1.593,400
RMTI
Rockwell Medical
1.6781 of 5 stars
$0.38
-7.9%
$5.00
-1,212.3%
-64.7%$35.80M$62.20M-1.06300
This page was last updated on 12/4/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.